Due to the increasing scientific and biomedical interest in various nanoparticles (NPs) showing excellent properties, a convenient and adjustable physical method with improved efficiency needs to be used for enabling tech-scale production of such promising NPs.
The current state-of-the art on NIR-II-activated photosensitizers and their applications for the deep tumor treatment, as well as recent efforts that combine NIR-II activated PDT with other complementary therapeutic routes.
• The main properties of coordinated magnetic nanoparticles (MNPs) including magnetic moment and saturated magnetisation). • The doping of transition metal ions into ferrite to precisely modulate its magnetic properties. • the potential mechanisms and recent advances in transition metal ion-doped MNPs (TMNPs) for bioimaging: magnetic resonance imaging and magnetic particle imaging and tumour therapy: e.g., magneto-mechanical killing, magnetothermal therapy, and drug delivery. • the current challenges and future trends of TMNPs in the biomedical field based on the latest advances by researchers.
1 February 2022 in Journal of Materials Chemistry B
Mitochondria, as the “the power plants” of cells, have been extensively studied because of their biological functions of providing energy and participating in signaling pathways. In parallel, calcium (Ca2+) plays a vital role in the homeostasis balance and function coordination of mitochondria, especially in cancer cells which metabolize frequently to maintain their growth. On this basis, Ca2+ overload has been an efficient, yet safe theranostic model for cancer therapy, by activating mitochondrial apoptosis pathways to achieve cancer suppression. However, the integration of functional units mediating Ca2+ overload into the nanoplatform remains a difficult but significant task. This review aims to highlight meaningful designs of nanoplatforms for Ca2+ overload, including monotherapy and combination therapy. In addition, perspectives on further development of Ca2+ overload are provided, mainly emphasizing scientific restrictions and future exploitation directions.
12 November 2020 in WIREs Nanomedicine and Nanobiotechnology